Articles > Popular publications > PR Newswire press releases > October-December 2006 > Monday, October 9

Article: Eisai Receives Summary Judgment Motion Decisions in U.S. Legal Action Over Aciphex(R) ANDA Filings.

Article from:
PR Newswire
Article date:
October 9, 2006
Copyright

TEANECK, N.J., Oct. 8 /PRNewswire/ -- Eisai Co., Ltd. (Headquarters: Tokyo, President and CEO: Haruo Naito) and Eisai Inc. (Headquarters: New Jersey, Chairman and CEO: Hajime Shimizu) today announce that they received court decisions on ANDA-related summary judgment motions for Aciphex(R) (Active Ingredient Name: rabeprazole sodium, Product Name in Japan: Pariet(R)) on October 6, 2006 (U.S. Eastern time).

The Southern District Court of New York granted Eisai's summary judgment motion confirming the validity of the Aciphex(R) composition of matter patent in its ruling. The Court reserved ruling on the enforceability arguments until after trial. Eisai looks ...

Read all of this article with a FREE trial

Related newspaper, magazine, and journal articles:

Article: Eisai Inc. Assumes U.S. Distribution Responsibilities for ...
PR Newswire;  January 7, 2004 ;     700+ words ... ... December 29, 2003, Eisai is fulfilling purchase orders for Aciphex(R) from a contract ... the distribution of Aciphex(R) to Eisai marks the accomplishment ... tablets), and now, Aciphex(R), further enhances Eisai's capabilities as ...

Article: U.S. Federal Circuit Court of Appeals Fully Upholds ...
PR Newswire;  July 21, 2008 ;     700+ words ... ... summary judgment to Eisai, upholding the validity of the Aciphex(R) composition ... and Germany. Aciphex(R) was discovered and developed by Eisai and is copromoted ... http://www.aciphex.com/. About Eisai Co., Ltd. Eisai ...

Article: Eisai Obtains Favorable Ruling in Aciphex(R) Patent ...
PR Newswire;  May 11, 2007 ;     700+ words ... ... Chairman & CEO of Eisai Inc. Aciphex(R) is classified as a ... In the United States, Eisai Inc. copromotes Aciphex(R) with PriCara(TM ... please visit http://www.eisai.com/. About Aciphex(R) Aciphex(R) has ...

Article: Rabeprazole Delayed Release Tablets (Aciphex-Eisai ...
Internal Medicine Alert;  September 29, 1999 ;     700+ words ... ... and gastroesophageal reflux disease (GERD). Rabeprazole (Aciphex) joins omeprazole (Prilosec) and lansoprazole (Prevacid ... worldwide market. Rabeprazole will be comarketed in this country by Eisai Inc and Janssen Pharmaceutica. The drug is a pyridyl methysulfinyl ...

Article: Rabeprazole Delayed Release Tablets (Aciphex--Eisai ...
Internal Medicine Alert;  September 29, 1999 ;     700+ words ... ... and gastroesophageal reflux disease (GERD). Rabeprazole (Aciphex) joins omeprazole (Prilosec) and lansoprazole (Prevacid ... worldwide market. Rabeprazole will be comarketed in this country by Eisai Inc and Janssen Pharmaceutica. The drug is a pyridyl methysulfinyl ...

Article: Aricept and Aciphex boost Eisai ...
Pharma Marketletter;  June 6, 2005 ;     700+ words ...Japan's Eisai reported solid consolidated results for ... Aricept (donepezil) and the antiulcerant Aciphex/Pariet (rabeprazole). Total revenues ... targets. Update on R&D progress Eisai also updated the status of proof-of ...

Article: Aricept and Aciphex lead Eisai's growth.(Brief ...
Pharma Marketletter;  August 15, 2005 ;     620 words ...Japanese pharmaceutical firm Eisai has reported better-than-expected ... mild-to-moderate AD. Turnover of Aciphex/Pariet (rabeprazole) was 12.5 ... strong performance of drugs enabled Eisai's US subsidiary to post sales of ...

Article: U.S. Federal Circuit Court of Appeals Fully Upholds ...
Biotech Week;  August 6, 2008 ;     700+ words ... ... summary judgment to Eisai, upholding the validity of the Aciphex(R) composition ... Eisai Inc. "Eisai will continue ... the world." Aciphex(R) is classified ... and Germany. Aciphex(R) was discovered ... and developed by Eisai and is copromoted ...

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!

Find articles, research, and archives